神經系統疾病的新治療法：幹細胞療法

本報告已在2011年12月21日停止出版。

簡介

目錄

Abstract

Introduction

Stem cell therapy development is challenged by controversy, intellectual property issues, and a high failure rate. Despite these challenges, stem cell therapy presents some of the most promising options for hard-to-treat and highly degenerative neurological diseases.

Get the Answers You Need to Shape Your Strategy

Stem cell therapy holds vast potential for treating degeneration or injury in areas of the body that are incapable of autonomous healing, such as the central nervous system (CNS). How can stem cells boost healing in the CNS? What are the limitations of these therapies in the CNS? What scientifi c and regulatory roadblocks exist for developing stem cell therapies for the CNS? Several manufacturers are investigating stem cell therapies to treat neurological disease. What are the different approaches for developing these therapies? What value do different stem cell therapies offer, and what challenges do they face? How might these agents impact the different disease markets?

Stem cell therapies may represent the fi rst true disease-modifying therapies for multiple neurological diseases, but their success will depend on many factors, including ethics, clinical trial design, and safety concerns. How are ethics affecting stem cell design? What can we expect from future stem cell clinical trials? Which stem cell therapies are likely to offer the best safety profi les?

Scope

• Stem cell introduction: stages of stem cell differentiation, comparison of stem cell types, history of stem cell development.
• Value of stem cells for neurological diseases: benefi ts and limitations of stem cells and their therapeutic value for multiple neurological indications, including Alzheimer' s disease and Parkinson' s disease.
• Emerging stem cell therapies for neurological uses: discussion of multiple companies' initiatives into developing neurological stem cell therapies.
• Outlook: hurdles for stem cell therapy development, discussion of which stem cell therapies are more likely to succeed.

Mentioned in This Spectrum Report

Companies

• Advanced Cell Technology
• Athersys
• Berlex
• Boehringer Ingelheim
• BrainStorm Cell Therapeutics
• Ferrer Internacional
• Genentech
• Geron
• Kyowa Hakko
• Mitsubishi Pharma
• ReNeuron Group
• Saneron CCel
• Sanofi -Aventis
• Schering
• Stem Cell Therapeutics
• StemCells
• Titan Pharmaceuticals

Table of Contents

• Executive Summary
• Strategic Considerations
• Stakeholder Implications
• Introduction
• Overview of Stem Cell Development
• History of Stem Cell Research
• Potential of Stem Cell Therapies in Neurological Disease
• Stroke
• Alzheimer' s Disease
• Parkinson' s Disease
• Spinal Cord Injury
• Multiple Sclerosis
• Huntington' s Disease
• Amyotrophic Lateral Sclerosis
• Lysosomal Storage Diseases
• Leading Companies in Stem Cell Therapeutics for Neurological Disease
• StemCells
• Geron
• ReNeuron Group
• Stem Cell Therapeutics
• Athersys
• BrainStorm Cell Therapeutics
• Advanced Cell Technology
• Saneron CCel
• Outlook

Tables

• 1. Types of Stem Cells
• 2. Neurological Disorders That May Benefit from Stem Cell Therapy
• 3. Key Research Studies on Stem Cells in Stroke
• 4. Key Research Studies on Stem Cells in Alzheimer' s Disease
• 5. Key Research Studies on Stem Cells in Parkinson' s Disease
• 6. Key Research Studies on Stem Cells in Spinal Cord Injury
• 7. Companies Developing Stem Cell Therapies

Figures

• 1. Stem Cell Differentiation
• 2. Important Events in the History of Stem Cell Research
• 3. Government Policies Regarding Stem Cell Research

相關商品

神經疾病相關市場調查報告書

疼痛治療藥市場的發展：侵害受容性及神經性疼痛治療藥的開發
Evolution in the Pain Therapy Drugs Market: Nociceptive and Neuropathic Drug Development
價格 : US $ 2265
出版日期 : 2012年01月

神經保護：醫療藥品・市場・企業
Neuroprotection - Drugs, Markets and Companies
價格 : US $ 5000
出版日期 : 2012年01月

阿茲海默症：新藥・市場・企業
Alzheimer disease - new drugs, markets and companies
價格 : US $ 3500
出版日期 : 2012年01月

Decision Resources, Inc.發行的製藥相關市場調查報告書

傳染病疫苗開發平台:競爭檢討

Special Report: The Infectious Disease Vaccine Pipeline--A Competitive Review

價格 : US $ 9200

出版日期 : 2011年06月

感染疾病疫苗:未滿足需求和對醫藥品產業來說的機會

Special Report: Infectious Disease Vaccines--Unmet Needs and Opportunities for Pharma

價格 : US $ 9200

出版日期 : 2011年06月

自閉症譜系障礙:高未滿足需求創造出很大的市場機會

Special Report: Autism Spectrum Disorders--High Unmet Needs Create Significant Market Opportunities

價格 : US $ 9200

出版日期 : 2011年06月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!